Publications
Detailed Information
Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: A multicenter study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Won Ki | - |
dc.contributor.author | Byun, Seok-Soo | - |
dc.contributor.author | Kim, Hyeon Hoe | - |
dc.contributor.author | Rha, Koon Ho | - |
dc.contributor.author | Sung, Gyung Tak | - |
dc.contributor.author | Lim, Jae Sung | - |
dc.contributor.author | Kwon, Tae Gyun | - |
dc.contributor.author | Jeong, Young Beom | - |
dc.contributor.author | Lee, Wan | - |
dc.contributor.author | Hwang, Tae-Kon | - |
dc.date.accessioned | 2012-06-14T06:15:20Z | - |
dc.date.available | 2012-06-14T06:15:20Z | - |
dc.date.issued | 2010-11 | - |
dc.identifier.citation | INTERNATIONAL JOURNAL OF UROLOGY; Vol.17 11; 898-904 | ko_KR |
dc.identifier.issn | 0919-8172 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77070 | - |
dc.description.abstract | Objectives: To analyze the characteristics and the prognostic significance of chromophobe renal cell carcinomas (chRCC). Methods: Data about 2981 patients with non-metastatic renal cell carcinomas (RCC) at the time of surgery were retrospectively collected from 26 institutions between 1998 and 2008. All patients had undergone partial or radical nephrectomies. Of the 2981 patients, 2602 patients with conventional RCC (cRCC) and 148 with chRCC were studied. Clinical and pathological parameters were determined in all patients. Recurrence-free survival (RFS) and cancer-specific survival (CSS) were assessed. Results: Patients with chRCC differed significantly from those with cRCC on the following parameters: younger age (P = 0.026), greater female ratio (P < 0.001), and larger tumor diameter (P < 0.001). Both groups were alike with respect to body mass index (P = 0.943), Eastern Cooperative Oncology Group performance status (P = 0.163), T stage (P = 0.375), and Fuhrman`s grade (P = 0.134). The 5-year RFS rates in patients with chRCC and cRCC were 82.7% and 83.3%, respectively (P = 0.762). The 5-year CSS rates in patients with chRCC and cRCC were 88.8% and 92.2%, respectively (P = 0.980). Both groups showed equivalent oncological outcomes in terms of RFS and CSS for cases stratified by T stage and Fuhrman`s grade. In multivariate analysis, the histological subtype was not retained as an independent prognostic variable (RFS: P = 0.893; CSS: P = 0.729). Conclusions: Despite being significantly different from cRCC in terms of several clinical and pathological parameters, chRCC shows equivalent oncological outcomes. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | WILEY-BLACKWELL | ko_KR |
dc.subject | chromophobe | ko_KR |
dc.subject | survival | ko_KR |
dc.subject | renal cell carcinoma | ko_KR |
dc.subject | pathology | ko_KR |
dc.subject | conventional | ko_KR |
dc.title | Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: A multicenter study | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이원기 | - |
dc.contributor.AlternativeAuthor | 변석수 | - |
dc.contributor.AlternativeAuthor | 김현회 | - |
dc.contributor.AlternativeAuthor | 라군호 | - |
dc.contributor.AlternativeAuthor | 황태곤 | - |
dc.contributor.AlternativeAuthor | 성경탁 | - |
dc.contributor.AlternativeAuthor | 이완 | - |
dc.contributor.AlternativeAuthor | 임재성 | - |
dc.contributor.AlternativeAuthor | 정용범 | - |
dc.contributor.AlternativeAuthor | 권태균 | - |
dc.identifier.doi | 10.1111/j.1442-2042.2010.02630.x | - |
dc.citation.journaltitle | INTERNATIONAL JOURNAL OF UROLOGY | - |
dc.description.citedreference | Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035 | - |
dc.description.citedreference | Waldert M, 2010, EUR UROL, V57, P661, DOI 10.1016/j.eururo.2009.05.009 | - |
dc.description.citedreference | Teloken PE, 2009, J UROLOGY, V182, P2132, DOI 10.1016/j.juro.2009.07.019 | - |
dc.description.citedreference | Stec R, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-134 | - |
dc.description.citedreference | Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006 | - |
dc.description.citedreference | Capitanio U, 2009, BJU INT, V103, P1496, DOI 10.1111/j.1464-410X.2008.08259.x | - |
dc.description.citedreference | Eichelberg C, 2009, EUR UROL, V55, P851, DOI 10.1016/j.eururo.2009.01.003 | - |
dc.description.citedreference | Amin MB, 2008, AM J SURG PATHOL, V32, P1822 | - |
dc.description.citedreference | Klatte T, 2008, UROL ONCOL-SEMIN ORI, V26, P604, DOI 10.1016/j.urolonc.2007.07.015 | - |
dc.description.citedreference | Tickoo SK, 2008, UROL CLIN N AM, V35, P551, DOI 10.1016/j.ucl.2008.07.001 | - |
dc.description.citedreference | Raj GV, 2008, J UROLOGY, V179, P2146, DOI 10.1016/j.juro.2008.01.101 | - |
dc.description.citedreference | Karakiewicz PI, 2007, J CLIN ONCOL, V25, P1316, DOI 10.1200/JCO.2006.06.1218 | - |
dc.description.citedreference | Pignot G, 2007, UROLOGY, V69, P230, DOI 10.1016/j.urology.2006.09.052 | - |
dc.description.citedreference | Delahunt B, 2007, PATHOLOGY, V39, P459, DOI 10.1080/00313020701570061 | - |
dc.description.citedreference | CAMPBELL SC, 2007, CAMPBELLWALSH UROLOG, P2762 | - |
dc.description.citedreference | Shuch BM, 2006, SEMIN ONCOL, V33, P563, DOI 10.1053/j.seminoncol.2006.06.006 | - |
dc.description.citedreference | Cohen HT, 2005, NEW ENGL J MED, V353, P2477 | - |
dc.description.citedreference | Cindolo L, 2005, CANCER, V104, P1362, DOI 10.1002/cncr.21331 | - |
dc.description.citedreference | Schuetz AN, 2005, J MOL DIAGN, V7, P206 | - |
dc.description.citedreference | Patard JJ, 2005, J CLIN ONCOL, V23, P2763, DOI 10.1200/JCO.2005.07.055 | - |
dc.description.citedreference | LAM JS, 2005, CURR UROL REP, V6, P7 | - |
dc.description.citedreference | Kim H, 2004, HUM PATHOL, V35, P1556, DOI 10.1016/j.humpath.2004.06.011 | - |
dc.description.citedreference | Patard JJ, 2004, J CLIN ONCOL, V22, P3316, DOI 10.1200/JCO.2004.09.104 | - |
dc.description.citedreference | Furge KA, 2004, CANCER RES, V64, P4117 | - |
dc.description.citedreference | Beck SDW, 2004, ANN SURG ONCOL, V11, P71, DOI 10.1245/ASO.2004.06.016 | - |
dc.description.citedreference | EBLE JN, 2004, WHO CLASSIFICATION T, P12 | - |
dc.description.citedreference | GREENE FL, 2002, AJCC CANC STAGING MA, P323 | - |
dc.description.citedreference | Kattan MW, 2001, J UROLOGY, V166, P63 | - |
dc.description.citedreference | Kovacs G, 1997, J PATHOL, V183, P131 | - |
dc.description.citedreference | Delahunt B, 1997, MODERN PATHOL, V10, P537 | - |
dc.description.citedreference | FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655 | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.